Journal Article
. 2006 Apr; 17(6):1665-72.
doi: 10.1681/ASN.2006010090.

Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection

Ariela Benigni 1 Susanna Tomasoni  Laurence A Turka  Lorena Longaretti  Lorena Zentilin  Marilena Mister  Anna Pezzotta  Nadia Azzollini  Marina Noris  Sara Conti  Mauro Abbate  Mauro Giacca  Giuseppe Remuzzi  
  • PMID: 16641148
  •     8 citations


Short-term results of renal transplantation have improved considerably in the past 20 yr; however, similar improvements in long-term outcome have not been achieved. The primary cause of late graft loss is chronic rejection that might be treated by gene therapeutic approaches. Ideally, one would like to impair locally the contact between transplant antigen and the host immune system without compromising the generalized immune competence of the recipient. This can be achieved by local expression of the therapeutic protein in the site of interest using gene therapy. Here it is shown that chronic allograft rejection can be prevented effectively by local delivery of recombinant adeno-associated virus (AAV) vectors that encode the CTLA4Ig immunosuppressant protein to the donor kidney in a fully MHC-mismatched rat strain combination. AAV CTLA4Ig prevented progressive proteinuria and protected transplant kidneys from renal structural injury. A population of anergic T cells with regulatory activity, which eventually were responsible for the induction of tolerance, were found in recipient lymph nodes and in the graft as long as 120 d after transplantation. These data indicate that AAV-mediated CTLA4Ig gene transfer to donor graft represents a promising tool to prevent the onset of chronic rejection and circumvent the unwanted systemic adverse effects of the administration of immunomodulatory protein.

Xenotransplantation: the next generation of engineered animals.
Anthony J F d'Apice, Peter J Cowan.
Transpl Immunol, 2008 Nov 01; 21(2). PMID: 18973810    Free PMC article.
Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.
Antony Vinh, Wei Chen, +6 authors, Tomasz J Guzik.
Circulation, 2010 Dec 04; 122(24). PMID: 21126972    Free PMC article.
Highly Cited.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Experimental rat models of chronic allograft nephropathy: a review.
Badri Shrestha, John Haylor.
Int J Nephrol Renovasc Dis, 2014 Aug 06; 7. PMID: 25092995    Free PMC article.
Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction.
D Vavrincova-Yaghi, L E Deelman, +7 authors, M Sandovici.
Gene Ther, 2016 Nov 04; 23(11). PMID: 27454318
Experimental Evaluation of Kidney Regeneration by Organ Scaffold Recellularization.
Andrea Remuzzi, Marina Figliuzzi, +5 authors, Giuseppe Remuzzi.
Sci Rep, 2017 Mar 08; 7. PMID: 28266553    Free PMC article.
AAV9-mediated engineering of autotransplanted kidney of non-human primates.
S Tomasoni, P Trionfini, +8 authors, A Benigni.
Gene Ther, 2017 Mar 28; 24(5). PMID: 28346435
Efficient Gene Transfer to Kidney Mesenchymal Cells Using a Synthetic Adeno-Associated Viral Vector.
Yoichiro Ikeda, Zhao Sun, +2 authors, Benjamin D Humphreys.
J Am Soc Nephrol, 2018 Jul 07; 29(9). PMID: 29976586    Free PMC article.